The vasorelaxant effect of antidiabetic drug nateglinide via activation of voltage-dependent K+ channels in aortic smooth muscle
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, Hongliang | - |
dc.contributor.author | Kim, Hye Won | - |
dc.contributor.author | Shin, Sung Eun | - |
dc.contributor.author | Seo, Mi Seon | - |
dc.contributor.author | An, Jin Ryeol | - |
dc.contributor.author | Jung, Won-Kyo | - |
dc.contributor.author | Ha, Kwon-Soo | - |
dc.contributor.author | Han, Eun-Taek | - |
dc.contributor.author | Hong, Seok-Ho | - |
dc.contributor.author | Bang, Hyoweon | - |
dc.contributor.author | Choi, Il-Whan | - |
dc.contributor.author | Na, Sung Hun | - |
dc.contributor.author | Park, Won Sun | - |
dc.date.available | 2019-01-22T14:08:20Z | - |
dc.date.issued | 2018-02 | - |
dc.identifier.issn | 1755-5914 | - |
dc.identifier.issn | 1755-5922 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/1211 | - |
dc.description.abstract | AimsWe investigated the vasorelaxant effect of nateglinide and its related mechanisms using phenylephrine (Phe)-induced precontracted aortic rings. MethodsArterial tone measurement was performed in aortic smooth muscle. ResultsThe application of nateglinide induced vasorelaxation in a concentration-dependent manner. Pretreatment with the large-conductance Ca2+-activated K+ (BKCa) channel inhibitor paxilline, the inwardly rectifying K+ (Kir) channel inhibitor Ba2+, and ATP-sensitive K+ (K-ATP) channel inhibitor glibenclamide did not affect the vasorelaxant effect of nateglinide. However, pretreatment with the voltage-dependent K+ (Kv) channel inhibitor 4-aminopyridine (4-AP) effectively reduced the vasorelaxant effect of nateglinide. Pretreatment with the Ca2+ inhibitor nifedipine and the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin did not change the vasorelaxant effect of nateglinide. Additionally, the vasorelaxant effect of nateglinide was not altered in the presence of an adenylyl cyclase, a protein kinase A, a guanylyl cyclase, or a protein kinase G inhibitor. The vasorelaxant effect of nateglinide was not affected by the elimination of the endothelium. In addition, pretreatment with a nitric oxide synthase inhibitor, L-NAME, and a small-conductance Ca2+-activated K+ (SKCa) channel inhibitor, apamin, did not change the vasorelaxant effect of nateglinide. ConclusionNateglinide induced vasorelaxation via the activation of the Kv channel independent of other K+ channels, Ca2+ channels, intracellular Ca2+ ([Ca2+](i)), and the endothelium. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY | - |
dc.title | The vasorelaxant effect of antidiabetic drug nateglinide via activation of voltage-dependent K+ channels in aortic smooth muscle | - |
dc.type | Article | - |
dc.identifier.doi | 10.1111/1755-5922.12299 | - |
dc.identifier.bibliographicCitation | CARDIOVASCULAR THERAPEUTICS, v.36, no.1 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000419684600001 | - |
dc.identifier.scopusid | 2-s2.0-85032226635 | - |
dc.citation.number | 1 | - |
dc.citation.title | CARDIOVASCULAR THERAPEUTICS | - |
dc.citation.volume | 36 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | Aortic smooth muscle | - |
dc.subject.keywordAuthor | Nateglinide | - |
dc.subject.keywordAuthor | Vasorelaxation | - |
dc.subject.keywordAuthor | Voltage-dependent K+ channel | - |
dc.subject.keywordPlus | DIABETIC FATTY RATS | - |
dc.subject.keywordPlus | MESENTERIC-ARTERIES | - |
dc.subject.keywordPlus | RELAXATION | - |
dc.subject.keywordPlus | PULMONARY | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | MODULATION | - |
dc.subject.keywordPlus | LACKING | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.